TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
PBLS

Parabilis Medicines, Inc.

Healthcare · Biotechnology

27.50$ -2.2% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PBLS
Line item Q1 25 Q2 25 Q1 26 Q2 26
– – 100.0% 100.0%
– – 86.4% 95.8%
– – 85.6% 92.5%
– – 85.6% 95.4%
– – 36.4% 10.9%
– – 14.1% 5.3%
– – 4.5% 1.2%
– – 3.9% 1.6%
– – 63.6% 89.1%
– – -152.7% -54.4%
– – 0.5% 2.5%

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?